Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.
By P. Loehrer, Yang Feng, H. Cardenes, L. Wagner, J. Brell, D. Cella, P. Flynn, R. Ramanathan, C. Crane, S. Alberts and 1 more. Journal of Clinical Oncology, 2011
748 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/46be30b8815defee95f0b5d7742637b0106dd03e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Recent progress in pancreatic cancer (2013, background): “14).(127,163,172-174) More contemporary studies using aggressive induction sys-”
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, methodology): “2 months) yet toxicity also increased by combining the treatment modalities [40] [II, C].”